PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-198.26%
Both yoy net incomes decline, with CSIQ at -140.14%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-0.31%
Negative yoy D&A while CSIQ is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
95.69%
Deferred tax of 95.69% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-0.12%
Both cut yoy SBC, with CSIQ at -70.39%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
11187.25%
Working capital change of 11187.25% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
-253.01%
AR is negative yoy while CSIQ is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
81.98%
Inventory growth of 81.98% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
34640.94%
AP growth of 34640.94% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
931.39%
Growth of 931.39% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
947.84%
Some yoy increase while CSIQ is negative at -101.98%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
862.29%
CFO growth of 862.29% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a modest edge that could widen if cost discipline remains strong.
-360.94%
Negative yoy CapEx while CSIQ is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Purchases growth of 100.00% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
No Data
No Data available this quarter, please select a different quarter.
-899.45%
We reduce yoy other investing while CSIQ is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-569.35%
We reduce yoy invests while CSIQ stands at 0.00%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-137.35%
We cut debt repayment yoy while CSIQ is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
100.00%
Issuance growth of 100.00% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-15.49%
We cut yoy buybacks while CSIQ is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.